Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8423721 | 0.89 | ALDH1A1 (0.39) | ALDH1A1CRBNSMN1; SMN2HPGDCTSK | |
| SCHEMBL8425464 | 0.89 | S1PR5 (0.44) | ALDH1A1MEN1KMT2ALMNAHPGD | |
| SCHEMBL8424170 | 0.86 | ALDH1A1 (0.49) | ALDH1A1POLBMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL8423697 | 0.79 | MMP2 (0.43) | ALDH1A1POLBMEN1KMT2ALMNA | |
| SCHEMBL8424066 | 0.77 | HPGD (0.43) | ALDH1A1MEN1KMT2ASMN1; SMN2HPGD | |
| SCHEMBL8423588 | 0.75 | ALDH1A1 (0.43) | ALDH1A1POLBMEN1KMT2ALMNA | |
| SCHEMBL8427523 | 0.71 | ALDH1A1 (0.46) | ALDH1A1POLBMEN1KMT2ALMNA | |
| SCHEMBL6858259 | 0.70 | ADAM17 (0.47) | — | |
| SCHEMBL8425302 | 0.69 | MMP2 (0.50) | ALDH1A1MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL5139048 | 0.69 | ALDH1A1 (0.59) | ALDH1A1POLBMEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5932595-A | ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT | SYNTEX (U.S.A.) INC. (US) | 1999-08-03 | — | — | US | disclosed |